Tong Xu Selected Research

Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)

10/2015	Remission Rate and Functional Outcomes During a 6-Month Treatment With Osmotic-Release Oral-System Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder.
10/2011	Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder.
1/2008	l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tong Xu Research Topics

Disease

48	Neoplasms (Cancer) 04/2024 - 07/2006
27	Inflammation (Inflammations) 04/2024 - 02/2006
10	Infections 01/2024 - 11/2013
9	Fibrosis (Cirrhosis) 02/2024 - 11/2009
8	Neoplasm Metastasis (Metastasis) 04/2024 - 09/2010
7	Type 2 Diabetes Mellitus (MODY) 02/2024 - 10/2019
7	Myocardial Infarction 02/2024 - 01/2021
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2004
6	Lung Neoplasms (Lung Cancer) 12/2023 - 01/2016
6	Carcinoma (Carcinomatosis) 03/2021 - 10/2005
6	Acute Lung Injury 09/2019 - 11/2013
5	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 01/2018
5	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2019
5	Wounds and Injuries (Trauma) 03/2023 - 08/2016
5	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2021
5	Hypoxia (Hypoxemia) 06/2022 - 11/2006
5	Liver Diseases (Liver Disease) 01/2022 - 04/2014
5	Insulin Resistance 06/2021 - 10/2009
5	Circulating Neoplastic Cells 01/2021 - 08/2010
5	Orthomyxoviridae Infections 11/2017 - 04/2014
4	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2021
4	Carcinogenesis 11/2023 - 01/2014
4	Cognitive Dysfunction 01/2023 - 01/2020
4	Ischemic Stroke 01/2023 - 01/2021
4	Colonic Neoplasms (Colon Cancer) 11/2022 - 07/2005
4	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2016
4	Rabies (Hydrophobia) 07/2022 - 01/2020
4	Pulmonary Edema 05/2017 - 11/2006
3	Cardiotoxicity 04/2024 - 06/2022
3	Parkinson Disease (Parkinson's Disease) 01/2024 - 07/2022
3	Hemolysis 01/2024 - 10/2017
3	Periodontitis 01/2024 - 11/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 11/2020
3	Virus Diseases (Viral Diseases) 01/2024 - 11/2006
3	Atherosclerosis 11/2023 - 11/2019
3	Pain (Aches) 06/2022 - 04/2014
3	Abdominal Aortic Aneurysm 03/2022 - 07/2020
3	Body Weight (Weight, Body) 06/2021 - 11/2006
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2015 - 01/2008
2	Rupture 03/2024 - 03/2022
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2024 - 01/2023
2	Iron Overload 01/2024 - 01/2022
2	Heart Diseases (Heart Disease) 01/2024 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 11/2022
2	Ascites 01/2024 - 06/2011

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2012
7	Small Interfering RNA (siRNA)IBA 12/2023 - 02/2010
6	Therapeutic UsesIBA 01/2022 - 07/2015
5	Polystyrenes (Polystyrene)IBA 03/2024 - 09/2022
5	CollagenIBA 02/2024 - 11/2009
5	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2008
5	EnzymesIBA 02/2024 - 09/2011
5	AntioxidantsIBA 01/2024 - 09/2014
5	LipopolysaccharidesIBA 07/2023 - 11/2016
5	AntigensIBA 01/2022 - 10/2005
5	CytokinesIBA 11/2020 - 07/2005
5	HydrogelsIBA 11/2019 - 08/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 05/2022
4	Diethylhexyl Phthalate (DEHP)IBA 03/2024 - 01/2020
4	SeleniumIBA 01/2024 - 05/2023
4	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 07/2015
4	CateninsIBA 03/2023 - 01/2014
4	Combined VaccinesIBA 07/2022 - 01/2020
4	Interleukin-6 (Interleukin 6)IBA 06/2021 - 11/2006
4	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2015 - 02/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 11/2022
3	MicroplasticsIBA 04/2024 - 09/2022
3	phthalic acid (phthalate)IBA 03/2024 - 01/2020
3	Adenosine Triphosphate (ATP)IBA 11/2023 - 01/2021
3	Transcription Factors (Transcription Factor)IBA 09/2023 - 01/2021
3	VaccinesIBA 01/2023 - 01/2022
3	Matrix Metalloproteinases (MMPs)IBA 11/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2019
3	andrographolideIBA 04/2022 - 01/2021
3	DiterpenesIBA 04/2022 - 03/2019
3	Glutathione (Reduced Glutathione)IBA 01/2022 - 10/2012
3	Blood Glucose (Blood Sugar)IBA 06/2021 - 10/2019
3	LipidsIBA 01/2021 - 02/2006
3	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2015
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2015
2	Amino Acids FDA Link 04/2024 - 01/2023
2	Peptides (Polypeptides)IBA 04/2024 - 06/2016
2	buyang huanwuIBA 02/2024 - 04/2022
2	ImmunosorbentsIBA 02/2024 - 11/2020
2	InflammasomesIBA 02/2024 - 01/2024
2	IronIBA 01/2024 - 01/2022
2	Sirtuin 1IBA 01/2024 - 01/2021
2	Carrier Proteins (Binding Protein)IBA 01/2024 - 01/2021
2	Protein Isoforms (Isoforms)IBA 01/2024 - 11/2022
2	NucleoproteinsIBA 01/2024 - 04/2014
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2024 - 11/2022
2	bisphenol AIBA 12/2023 - 05/2023
2	SolutionsIBA 12/2023 - 05/2009
2	6-methyladenineIBA 12/2023 - 03/2023

Therapy/Procedure

16	Therapeutics 04/2024 - 05/2009
7	Drug Therapy (Chemotherapy) 01/2024 - 07/2015
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2022 - 01/2016
4	Radiotherapy 02/2011 - 07/2006
3	Tibetan Traditional Medicine (Traditional Tibetan Medicine) 06/2022 - 01/2018
2	Immunotherapy 01/2024 - 01/2022